(S)-Bleximenib (oxalate)

• UNSPSC Description:

  (S)-Bleximenib ((S)-Menin-MLL inhibitor 24) oxalate is a S-Enantiomer of (S)-Menin-MLL inhibitor 24 oxalate (HY-148669A). (S)-Bleximenib oxalate is a menin-mixed-lineage leukemia 1 (menin-MLL) inhibitor, and can be used for the research of cancer[1].

• Target Antigen:

  Epigenetic Reader Domain

• Type:

  Reference compound

• Related Pathways:

  Epigenetics

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/s-bleximenib-oxalate.html

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  COCCN(C)CCC[C@H](N1CC2(C1)CN(C3=NC=NN=C3OC4=C(C=C(C=C4)F)C(N(CC)C(C)C)=O)CC2)C(C)C.O=C(O)C(O)=O

• Molecular Weight:

  689.82

• References & Citations:

  [1]DASKALAKIS N, et, al. Combination therapies. WO2022237720A1.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported